Summit Therapeutics Inc. (SMMT) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SMMT Revenue Growth
Revenue Breakdown (FY 2022)
SMMT's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
By Geography
SMMT Revenue Analysis (2014–2025)
As of May 7, 2026, Summit Therapeutics Inc. (SMMT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, SMMT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $57.1 million in 2018.
Revenue diversification analysis shows SMMT's business is primarily driven by License and Service (100%). With over half of revenue concentrated in License and Service, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including KYMR (-12.6% YoY), TNGX (+48.3% YoY), and KRYS (+25.1% YoY). Compare SMMT vs KYMR →
SMMT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SMMTCurrent | $0 | - | - | - | |
 KYMR | $39M | -12.6% | +2.9% | -891.3% | |
 TNGX | $62M | +48.3% | +52.1% | -178.4% | |
 KRYS | $389M | +25.1% | - | 41.5% |
SMMT Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-1,094,374,000 | - |
| 2024 | $0 | - | $-15,007,000 | - | $-211,304,000 | - |
| 2023 | $0 | -100.0% | $-2,050,000 | - | $-89,736,000 | - |
| 2022 | $704K | -61.1% | $-1,810,000 | -257.0% | $-79,302,000 | -11259.8% |
| 2021 | $1.8M | +110.3% | $1.8M | 100.0% | $-86,186,000 | -4764.3% |
| 2020 | $860K | +36.1% | $860K | 100.0% | $-71,646,000 | -8330.9% |
| 2019 | $632K | -98.9% | $612K | 96.8% | $-42,764,767 | -6766.4% |
| 2018 | $57.1M | +302.9% | $56.4M | 98.8% | $5.4M | 9.4% |
| 2017 | $14.2M | +391.9% | $14.2M | 100.0% | $-25,829,000 | -182.3% |
| 2016 | $2.9M | +124.8% | $2.9M | 100.0% | $-31,065,000 | -1078.6% |
Full SMMT Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See SMMT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SMMT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SMMT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSMMT — Frequently Asked Questions
Quick answers to the most common questions about buying SMMT stock.
Is SMMT's revenue growth accelerating or slowing?
SMMT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is SMMT's long-term revenue growth rate?
Summit Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is SMMT's revenue distributed by segment?
SMMT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.